GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Interest Expense (Positive)

Noxopharm (ASX:NOX) Interest Expense (Positive)


View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.


Noxopharm (ASX:NOX) Business Description

Industry
Traded in Other Exchanges
Address
60 Linksley Ave, Glenhaven, NSW, AUS, 2156
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.